NSD3:癌症治疗的有希望的目标
Ting Huang1, Bowen Zhang1, Yifan Yang1
1Department of Basic Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
Cell biochemistry and function
|March 27, 2025
概括
核受体结合SET域蛋白3 (NSD3) 调节基因表达和稳定性. NSD3与癌症有关,推动了针对性治疗的研究,尽管存在抑制剂特异性的挑战.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 核受体结合SET域蛋白3 (NSD3) 是一个基基转移酶,向H3K36.
- NSD3在调节基因表达,基因组印记和基因组稳定性方面发挥着至关重要的作用.
- 通过放大,突变或融合,异常的NSD3活性与各种癌症有关.
研究的目的:
- 审查NSD3.3的结构,生物功能和癌症相关性.
- 分析NSD3在癌症特征背景下的作用.
- 讨论开发NSD3向癌症疗法的进展和挑战.
主要方法:
- 对NSD3的结构,功能和参与癌症的文献综述.
- 分析NSD3对已确定的癌症特征的作用.
- 审查关于NSD3抑制剂及其临床潜力的当前研究.
主要成果:
- 作为H3K36甲基转移酶的NSD3的功能影响关键的细胞过程.
- NSD3是瘤发生的一个重要因素,与多种癌症类型有关.
- 开发NSD3抑制剂是一个有前途的治疗策略,尽管特异性仍然是一个挑战.
结论:
- NSD3是正常生理学的关键调节剂,也是癌症发展的关键驱动因素.
- 准NSD3为新型癌症治疗提供了潜在的途径.
- 对选择性NSD3抑制剂的持续研究对于临床进展至关重要.
更多相关视频
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.3K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.5K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K